NPR’s Mary Louise Kelly talks with National Institutes of Health director Dr. Francis Collins about the new cystic fibrosis drug therapy that could benefit 90% of patients with the disease.
NPR’s Mary Louise Kelly talks with National Institutes of Health director Dr. Francis Collins about the new cystic fibrosis drug therapy that could benefit 90% of patients with the disease.